These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 15031575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
    Lanciego C, Pangua C, Chacón JI, Velasco J, Boy RC, Viana A, Cerezo S, García LG.
    AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus.
    Rowell NP, Gleeson FV.
    Cochrane Database Syst Rev; 2001 Aug; (4):CD001316. PubMed ID: 11687105
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
    Pierre MC, Chabbert V, Lozano S, Bigay-Game L, Lévêque N, Desloques L, Otal P, Rousseau H, Didier A, Mazières J.
    Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
    [Abstract] [Full Text] [Related]

  • 9. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
    Lanciego C, Chacón JL, Julián A, Andrade J, López L, Martinez B, Cruz M, García-García L.
    AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Superior vena cava obstruction in small-cell lung cancer.
    Chan RH, Dar AR, Yu E, Stitt LW, Whiston F, Truong P, Vincent MD, Kocha WI.
    Int J Radiat Oncol Biol Phys; 1997 Jun 01; 38(3):513-20. PubMed ID: 9231674
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
    Leung ST, Sung TH, Wan AY, Leung KW, Kan WK.
    Hong Kong Med J; 2015 Oct 01; 21(5):426-34. PubMed ID: 26139689
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review.
    Rowell NP, Gleeson FV.
    Clin Oncol (R Coll Radiol); 2002 Oct 01; 14(5):338-51. PubMed ID: 12555872
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.